Related Experiment Video
Updated: Jun 26, 2025

10:38
Evaluating the Differentiation Capacity of Mouse Prostate Epithelial Cells Using Organoid Culture
Published on: November 22, 2019
8.9K
Deciphering the Transcription Factor Landscape in Neuroendocrine Prostate Cancer Progression: A Novel Approach to
Biorxiv : the Preprint Server for Biology
|May 15, 2024
Summary
This study identifies transcription factor (TF) profiles in prostate cancer (PCa) subtypes, revealing dynamic shifts during neuroendocrine prostate cancer (NEPC) progression. These findings offer new therapeutic targets for resistant PCa.
Area of Science:
- Oncology
- Molecular Biology
- Bioinformatics
Background:
- Prostate cancer (PCa) is a major cause of cancer mortality in men.
- Neuroendocrine prostate cancer (NEPC) is a resistant subtype, and the role of transcription factors (TFs) in its development is unclear.
- Understanding TF dynamics is crucial for deciphering PCa progression to NEPC.
Approach:
- Developed a novel algorithmic approach to assess weighted TF expression in patient samples.
- Analyzed TF landscapes and dynamic shifts during NE transdifferentiation.
- Utilized enrichment and functional analyses across multiple clinical cohorts.
Key Points:
- Identified distinct TF profiles for prostatic adenocarcinoma (PRAD) and NEPC, including shared, PRAD-specific, and NEPC-specific TFs.
- Confirmed lineage specificity and clinical relevance of identified TF signatures.
- Uncovered novel TF candidates implicated in cell development, differentiation, and lineage determination, offering potential therapeutic targets.
Conclusions:
- Characterized lineage-specific TF profiles in PRAD and NEPC, highlighting dynamic TF landscape shifts during PCa progression.
- Proposed a three-phase hypothesis for NE transdifferentiation: de-differentiation, dormancy, and re-differentiation.
- Provided novel insights into the mechanisms driving PCa progression and NEPC development.
Related Concept Videos
Forced Transdifferentiation
1.9K
Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
Artificial...
1.9K
Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
Master Transcription Regulators
6.9K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
Transcription Factors
75.8K
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
75.8K
Methods of Nuclear Reprogramming
1.8K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K

